NEU 2.45% $16.73 neuren pharmaceuticals limited

Acadia, page-414

  1. 50 Posts.
    lightbulb Created with Sketch. 36
    I guess the US$7.3 billion enterprise value of this acquisition implies that Acadia’s global rights for Daybue are worth the same, meaning Acadia is worth $44.90 per share in a takeout for its Daybue rights, excluding the rest of its pipeline. Acadia is now trading at or about US$28.30. What takeout value can be interpolated for Neuren from this acquisition? Probably too soon to tell prior to impending phase 2 results.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.73
Change
0.400(2.45%)
Mkt cap ! $2.139B
Open High Low Value Volume
$16.49 $16.82 $16.44 $5.263M 315.7K

Buyers (Bids)

No. Vol. Price($)
2 64 $16.73
 

Sellers (Offers)

Price($) Vol. No.
$16.74 2 1
View Market Depth
Last trade - 13.48pm 12/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.